Evaluation of the estimated population prevalence of Helicobacter pylori infection and the frequency of achieving eradication after treatment based on the results of the 13C-urease breath test in individuals who applied to the federal network of the INVITRO laboratory (2019-2020, n=42,843)

Purpose of research. Assessment the population prevalence Helicobacter pylori infection and effectiveness eradication therapy by analyzing results 13 C-urease breath test ( C-UBT) surveyed patients who applied for to nationwide network medical offices INVITRO laboratory in 2019-2020. Materials methods. C-UBT was performed using C-UREA TEST kits IR spectrometer IRIS° - Doc, Kibion AB, Sweden. A brief questionnaire used when applying clarify purpose request, prior medication or gastric surgery. The evaluation helicobacteriosis among those screening, control, carried out comparison specified point examination test, based on a selected information from database 2019-2020 years (n=42843). Statistical calculations quantitative Excel, MS programs. Results. Primary screening H. goal 69% (n=26,127), control 31% (n=16,716) persons. According C-UBT, threshold positive 4.5% gray zone 3.0-4.5%, primary subjects, 39% had result, 3% doubtful, others negative. In group 40% subjects completed full course treatment. Among treatment, according remained 15%, as whole 17% patients. Conclusions. large initial examination, detection rate 39%, which probably reflects approximate current level this Russian Federation. testing treatment 80-82%.